Edition:
United States

Dynavax Technologies Corp (DVAX.OQ)

DVAX.OQ on NASDAQ Stock Exchange Capital Market

15.95USD
22 Jun 2018
Change (% chg)

$0.05 (+0.31%)
Prev Close
$15.90
Open
$15.90
Day's High
$16.05
Day's Low
$15.65
Volume
993,462
Avg. Vol
341,215
52-wk High
$24.45
52-wk Low
$8.15

Select another date:

Tue, May 8 2018

BRIEF-Dynavax Reports Q1 Loss Per Share Of $0.63

* Q1 EARNINGS PER SHARE VIEW $-0.49 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

BRIEF-Dynavax Technologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

* DYNAVAX TECHNOLOGIES CORPORATION ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) Source text for Eikon: Further company coverage:

BRIEF-Dynavax Provides New Durability Of Response Data For SD-101 In Combination With Keytruda In Melanoma

* DYNAVAX PROVIDES NEW DURABILITY OF RESPONSE DATA FOR SD-101 IN COMBINATION WITH KEYTRUDA (PEMBROLIZUMAB) IN MELANOMA AT THE 2018 AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING

BRIEF-Dynavax Qtrly Loss Per Share $0.45

* DYNAVAX REPORTS FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS

BRIEF-Dynavax Secures $175 Million In Non-Dilutive Debt Financing

* DYNAVAX SECURES $175 MILLION IN NON-DILUTIVE DEBT FINANCING

BRIEF-Dynavax Says Heplisav-B Available In U.S. For Prevention Of Hepatitis B In Adults

* DYNAVAX ANNOUNCES HEPLISAV-B™ IS NOW AVAILABLE IN THE UNITED STATES FOR THE PREVENTION OF HEPATITIS B IN ADULTS Source text for Eikon: Further company coverage:

Select another date: